Jos G W Kosterink

4PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 04, 2026
A Novel Hypothermic Preservation Formulation Containing SUL-138 Enables Long-Term Hypothermic Storage of Clinical-Grade CAR-T Cells.

|Feb 26, 2026
Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions.

Ilse A Pool, Antonius T Otten, Jos G W Kosterink

|Jan 24, 2025
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.

Anneke L Eerkens, Martha D Esajas, Koen Brummel

|Apr 11, 2018
Influence of protein properties and protein modification on biodistribution and tumor uptake of anticancer antibodies, antibody derivatives, and non-Ig scaffolds.

Frank-Jan Warnders, Marjolijn N Lub-de Hooge, Elisabeth G E de Vries

Pageof 1

Frequent Collaborators

1 joint publications

Frank-Jan Warnders

1 joint publications

Anneke L Eerkens

1 joint publications

Martha D Esajas

1 joint publications

Koen Brummel